Fractyl Health

#药闻简讯# $Fractyl Health(GUTS)$ 公布令人信服的 6 个月随机 REMAIN-1 中期数据，显示在 GLP-1 停用时使用 Revita®可持久维持体重
Revita是Fractyl Health公司的主力候选产品，旨在通过单次微创内镜手术重塑十二指肠内壁，以恢复因慢性代谢疾病而受损的健康营养感知与信号传导功...

#药闻简讯# 2025 年 12 月 2 日，专注于开创性治疗肥胖和 2 型糖尿病（T2D）根本原因的代谢疗法公司$Fractyl Health(GUTS)$ 今日宣布了其开放标签 REVEAL-1 队列的 6 个月积极结果。REVEAL-1 队列是一项开放标签研究，针对那些在 GLP-1 药物上至少减重 15%的肥胖个体，他们需要或选择停止 GLP-1 治...

Fractyl Health：公布REVEAL-1队列6个月开放标签数据，显示Revita手术（十二指肠粘膜水蒸汽消融术）帮助GLP-1停药患者维持体重，平均体重变化仅1.5%（对比典型10%反弹）。$Fractyl Health(GUTS)$
Helicore Biosciences：GIP拮抗剂HCR-188的I期研究已经完成，将以此为基础开发偶联药物。
T...

$Fractyl Health(GUTS)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001193125-26-012932  Size: 22 KB 网页链接

$Fractyl Health(GUTS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-323018  Size: 5 KB 网页链接

$Fractyl Health(GUTS)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-26-037247  Act: 34  Size: 8 KB 网页链接

$Fractyl Health(GUTS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-304486  Act: 34  Size: 433 KB 网页链接

$Fractyl Health(GUTS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-26-012975  Size: 5 KB 网页链接

$Fractyl Health(GUTS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-25-319524  Act: 34  Size: 257 KB 网页链接

$Fractyl Health(GUTS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-323017  Size: 5 KB 网页链接

$Fractyl Health(GUTS)$ S-8 Securities to be offered to employees in employee benefit plans Accession Number: 0001193125-26-011901  Act: 33  Size: 472 KB 网页链接

$Fractyl Health(GUTS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-310558  Size: 7 KB 网页链接

$Fractyl Health(GUTS)$ 8-K Current report, items 2.02, 8.01, and 9.01 Accession Number: 0001193125-26-001492  Act: 34  Size: 216 KB 网页链接

$Fractyl Health(GUTS)$ 8-K Current report, items 7.01, 8.01, and 9.01 Accession Number: 0001193125-26-028228  Act: 34  Size: 10 MB 网页链接

$Fractyl Health(GUTS)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001193125-26-048781  Act: 34  Size: 22 KB 网页链接

$Fractyl Health(GUTS)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001193125-25-323019  Size: 5 KB 网页链接

$Fractyl Health(GUTS)$ 8-K Current report, items 5.02, 7.01, and 9.01 Accession Number: 0001193125-26-003452  Act: 34  Size: 632 KB 网页链接